Skip to main content
AVIR logo

AVIR · Atea Pharmaceuticals, Inc. · Share Buybacks

Track AVIR — free
$3.96 +0.03 (+0.76%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$318.00M
Shares
80.30M
Volume · Nov 20 416.47K Avg daily vol (3M) 289.48K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$25,000,000
as of 2025-04-30
Remaining Authorization
$11,091,000
as of 2025-06-30 · not restated in filings since 2025-08-07
Program Utilization
55.6% $13,909,000 used of $25,000,000

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2025-12-31 $25,519,000
2024-12-31 $0
Key facts CIK 1593899 CUSIP 04683R106 13F (30d) 135 filings 118 filers Visit website Investor relations